HOME >> BIOLOGY >> NEWS
Experimental hantavirus vaccine elicits strong antibody response in primates

For the first time, scientists have demonstrated that an experimental vaccine to hantavirus pulmonary syndrome (HPS), a highly lethal disease, elicits a strong neutralizing antibody response in laboratory animals--a response that is key to preventing the virus from causing infection.

In addition, the antibodies, produced in nonhuman primates that received the vaccine, protected hamsters from disease even when administered 5 days after exposure.

These findings provide proof of concept in nonhuman primates for a vaccine against HPS, as well as for post exposure prophylactic treatment of HPS and a related disease known as hemorrhagic fever with renal syndrome (HFRS).

In an article published in last month's Journal of Virology, investigators at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) describe using a naked DNA approach to develop a hantavirus vaccine. The technique involves vaccination with plasmid DNA that encodes a specific hantavirus gene. When the plasmid DNA is introduced into the cells of a vaccine recipient, using a harmless device called a "gene gun," the cloned gene is expressed and presented to the immune system.

According to senior author Jay W. Hooper, Ph.D., the USAMRIID team constructed an expression plasmid containing the full-length M genome segment of Andes virus, a South American hantavirus. Vaccination with the plasmid elicited a potent neutralizing antibody response in rhesus macaques that were vaccinated a total of four times at three-week intervals.

To look at the duration of that response, the team collected serum samples for about six months. The monkeys who received the Andes vaccine displayed robust antibody levels as long as 25 weeks after the last vaccination.

Hantaviruses are carried by rodents and have caused epidemics in Europe, Asia, and the Americas. Some cause HPS, while others are responsible for the more common HFRS. The viruses are patho
'"/>

Contact: Caree Vander Linden
Caree.Vander-Linden@amedd.army.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases
23-Oct-2003


Page: 1 2 3

Related biology news :

1. Experimental drug shown to block mutant protein causing blood disease
2. Experimental smallpox DNA vaccine protects primates from lethal monkeypox
3. Experimental smallpox vaccine protects against monkeypox in nonhuman primates
4. Experimental Biology 2004 - Translating the Genome
5. Experimental Biology 2004 meets in Washington, D.C. April 17-21
6. Experimental cancer drugs may halt events that lead to cardiac hypertrophy and heart failure
7. Experimental Biology 2003 meets in San Diego April 11-15
8. Experimental Biology 2003 meets in San Diego April 11-15
9. Experimental gene switch increases lifespan with no ill effects
10. Experimental therapy stops allergic reactions in mice
11. APS awards 44 minority travel fellowships to the Experimental Biology 2002 meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2018)... ... September 10, 2018 , ... IONpathTM, a venture-backed ... new Multiplexed Ion Beam Imaging (MIBITM) technology was accepted by the journal Cell ... be shared during a webinar presented by Dr. Mike Angelo on October 2nd, ...
(Date:9/7/2018)... STATION, Texas (PRWEB) , ... September 05, 2018 ... ... Turnkey Facility Platform for a mAb manufacturing facility late last year, IPS-Integrated Project ... PODs for the manufacturing of autologous cell therapies. The iCON solution provides a ...
(Date:8/31/2018)... ... 30, 2018 , ... R3 Stem Cell, the nation's leader ... clients. The freezers are very convenient for practices to maintain regenerative biologics on ... amniotic and umbilical cord tissue. They are stored at -80 degrees Celsius, which ...
Breaking Biology News(10 mins):
(Date:8/21/2018)... ... August 21, 2018 , ... ... specializing in medical device compliance and commercialization, has just released a new ... Written and presented by Dr. Mario Kossmann, ESEP at the 28th Annual ...
(Date:8/17/2018)... ... 16, 2018 , ... The opening of the new Titusville facility marks the ... 2016. Chemko had a well established local presence, servicing the Space Coast since 1972. ... as the ongoing work at the Mobile Launch Platform (MLP) in support of NASA’s ...
(Date:8/17/2018)... , ... August 16, 2018 , ... ... announced their results from the AmbryShare project were published today in JAMA Oncology, ... the largest exome study ever conducted. , Every year hereditary breast cancer affects ...
(Date:8/14/2018)... ... August 13, 2018 , ... Labconco Corporation manufactures laboratory equipment, ... In addition, Labconco produces other lab equipment, such as glassware washers and freeze ... and consistency in design and manufacturing. , Through this webinar, which is ...
Breaking Biology Technology:
Cached News: